| pubmed-article:14683556 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C0017638 | lld:lifeskim |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C0431085 | lld:lifeskim |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C1171362 | lld:lifeskim |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C1515670 | lld:lifeskim |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C0042209 | lld:lifeskim |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:14683556 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:14683556 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:14683556 | pubmed:dateCreated | 2003-12-19 | lld:pubmed |
| pubmed-article:14683556 | pubmed:abstractText | In a syngeneic mouse brain tumor model, we tested the hypothesis that vaccination with tumor cells genetically modified to express B7.1 molecules induces tumor-specific T cells and immunological antitumor effects. | lld:pubmed |
| pubmed-article:14683556 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14683556 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14683556 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14683556 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14683556 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14683556 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:14683556 | pubmed:issn | 0148-396X | lld:pubmed |
| pubmed-article:14683556 | pubmed:author | pubmed-author:SuzukiMichiya... | lld:pubmed |
| pubmed-article:14683556 | pubmed:author | pubmed-author:YoshikawaKoic... | lld:pubmed |
| pubmed-article:14683556 | pubmed:author | pubmed-author:UchidaTetsuya... | lld:pubmed |
| pubmed-article:14683556 | pubmed:author | pubmed-author:KajiwaraKojiK | lld:pubmed |
| pubmed-article:14683556 | pubmed:author | pubmed-author:MoriokaJunJ | lld:pubmed |
| pubmed-article:14683556 | pubmed:author | pubmed-author:IdeguchiMakot... | lld:pubmed |
| pubmed-article:14683556 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14683556 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:14683556 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14683556 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14683556 | pubmed:pagination | 182-9; discussion 189-90 | lld:pubmed |
| pubmed-article:14683556 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:meshHeading | pubmed-meshheading:14683556... | lld:pubmed |
| pubmed-article:14683556 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14683556 | pubmed:articleTitle | Vaccine therapy for murine glioma using tumor cells genetically modified to express B7.1. | lld:pubmed |
| pubmed-article:14683556 | pubmed:affiliation | Department of Neurosurgery, Yamaguchi University School of Medicine, Yamaguchi, Japan. | lld:pubmed |
| pubmed-article:14683556 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14683556 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
